IL10 and COVID-19: The ability of the immunoregulatory cytokines axis, particularly TGF-β1 and IL-10, to quickly counteract systemic inflammatory cytokines such as IL-6 is a hallmark in survivors relative to non-survivors of COVID-19 (4).